Home Other Building Blocks 107444-51-9
107444-51-9,MFCD00133373
Catalog No.:AA008R2T

107444-51-9 | GLUCAGON-LIKE PEPTIDE I FRAGMENT 7-36 AMIDE HUMAN

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
>98%
2 weeks  
$61.00   $43.00
- +
50mg
98%
2 weeks  
$2,763.00   $1,934.00
- +
100mg
98%
2 weeks  
$3,711.00   $2,598.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA008R2T
Chemical Name:
GLUCAGON-LIKE PEPTIDE I FRAGMENT 7-36 AMIDE HUMAN
CAS Number:
107444-51-9
Molecular Formula:
C149H226N40O45
Molecular Weight:
3297.6297
MDL Number:
MFCD00133373
SMILES:
NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N)CCCNC(=N)N)CCCCN)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)[C@H](CC)C)Cc1ccccc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)N)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C
Properties
Computed Properties
 
Complexity:
7660  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
30  
Heavy Atom Count:
234  
Hydrogen Bond Acceptor Count:
50  
Hydrogen Bond Donor Count:
49  
Rotatable Bond Count:
109  
XLogP3:
-14.2  

Literature

Title: cAMP-mediated and metabolic amplification of insulin secretion are distinct pathways sharing independence of β-cell microfilaments.

Journal: Endocrinology 20121001

Title: Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.

Journal: Pharmacology 20050601

Title: S 23521 decreases food intake and body weight gain in diet-induced obese rats.

Journal: Obesity research 20041001

Title: Simultaneous determination of incretin hormones and their truncated forms from human plasma by immunoprecipitation and liquid chromatography-mass spectrometry.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040415

Title: Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).

Journal: Metabolism: clinical and experimental 20040201

Title: Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.

Journal: Diabetologia 20021001

Title: Evaluation of glycated glucagon-like peptide-1(7-36)amide in intestinal tissue of normal and diabetic animal models.

Journal: Biochimica et biophysica acta 20020115

Title: Involvement of calmodulin in glucagon-like peptide 1(7-36) amide-induced inhibition of the ATP-sensitive K+ channel in mouse pancreatic beta-cells.

Journal: Experimental physiology 20010501

Title: Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo.

Journal: The Journal of clinical endocrinology and metabolism 20010301

Title: The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20010101

Title: Kreymann B, et al. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987 Dec 5;2(8571):1300-4.

Title: Mentlein R, et al. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem. 1993 Jun 15;214(3):829-35.

Title: Nauck MA, et al. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993 Aug;36(8):741-4.

Title: Hansen L, et al. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology. 1999 Nov;140(11):5356-63.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:107444-51-9 Molecular Formula|107444-51-9 MDL|107444-51-9 SMILES|107444-51-9 GLUCAGON-LIKE PEPTIDE I FRAGMENT 7-36 AMIDE HUMAN